Pons-Rodriguez Anna, Marzo-Castillejo Mercè, Cruz-Esteve Inés, Galindo-Ortego Gisela, Hernández-Leal Maria José, Rué Montserrat
ABS Eixample, Institut Català de la Salut, Lleida, España.
Unitat de Suport a la Recerca Metropolitana Sud, IDIAP Jordi Gol, Direcció d'Atenció Primària Costa de Ponent, Institut Català de la Salut, Barcelona, España.
Aten Primaria. 2022 May;54(5):102288. doi: 10.1016/j.aprim.2022.102288. Epub 2022 Apr 25.
Breast cancer is the leading cause of death in the world among women. The Spanish National Health System (SNHS) introduced population-based breast cancer screening in 1990. As in most European programs, risk is identified on the basis of age and a mammogram is offered every two years to women aged 50-69 years. Scientific evidence is moving toward personalized screening, based on individual risk. This article presents the clinical trials that will evaluate the efficacy of personalized screening and some studies carried out in our environment on the effect of informing women of the benefits and adverse effects of screening or the acceptability and feasibility of offering personalized screening, in the Shared Decision Making context. The Preventive Activities and Health Promotion Program can help transform screening in our SNHS.
乳腺癌是全球女性的首要死因。西班牙国家卫生系统(SNHS)于1990年引入了基于人群的乳腺癌筛查。与大多数欧洲项目一样,风险是根据年龄来确定的,每两年为50至69岁的女性提供一次乳房X光检查。科学证据正朝着基于个体风险的个性化筛查发展。本文介绍了将评估个性化筛查效果的临床试验,以及在我们的环境中开展的一些研究,这些研究涉及在共同决策背景下告知女性筛查的益处和不良影响,或提供个性化筛查的可接受性和可行性。预防活动与健康促进项目有助于改变我们SNHS中的筛查方式。